{
  "context": [
    {
      "name": "psoriasis",
      "type": "disease"
    }
  ],
  "entities": {
    "IL17A": [
      "Gene/RNA",
      "up"
    ],
    "Alkbh5": [
      "Gene/RNA",
      "none"
    ],
    "Mettl3": [
      "Gene/RNA",
      "none"
    ],
    "N6-methyladenosine": [
      "Epitranscriptomic modification",
      "up"
    ],
    "CD4+ T cells": [
      "Tissue/Cell Type",
      "none"
    ],
    "psoriasis": [
      "Disease",
      "none"
    ]
  },
  "relations": [
    {
      "head": "Mettl3",
      "tail": "N6-methyladenosine",
      "label": "methylate",
      "metaRelations": [],
      "text": "Intriguingly, this phenotype and inflammation were alleviated by the ablation of the m6 A methyltransferase Mettl3 in CD4+ T cells."
    },
    {
      "head": "Alkbh5",
      "tail": "N6-methyladenosine",
      "label": "remove",
      "metaRelations": [],
      "text": "In the psoriasis mouse model, depletion of the RNA demethylase, Alkbh5, from CD4+ T cells promoted the psoriasis-like phenotype and inflammation."
    },
    {
      "head": "N6-methyladenosine",
      "tail": "IL17A",
      "label": "is on",
      "metaRelations": [],
      "text": "Mechanistically, we found that the m6 A modification of IL17A mRNA increased the expression of IL-17A (an important pro-inflammatory factor in psoriasis) and promoted psoriasis."
    },
    {
      "head": "IL17A",
      "tail": "psoriasis",
      "label": "promote",
      "metaRelations": [],
      "text": "Mechanistically, we found that the m6 A modification of IL17A mRNA increased the expression of IL-17A (an important pro-inflammatory factor in psoriasis) and promoted psoriasis."
    }
  ],
  "analysis": "Context:  \n• Psoriasis (disease)\n\nNodes:  \n1) IL17A → Gene/RNA  \n2) Alkbh5 → Gene/RNA  \n3) Mettl3 → Gene/RNA  \n4) N6-methyladenosine → Epitranscriptomic modification  \n5) CD4+ T cells → Tissue/Cell Type  \n6) Psoriasis → Disease  \n\nRegulatory Relationships (direct):  \n1) Mettl3 methylates N6-methyladenosine (meta-effect: increases IL17A)  \n2) Alkbh5 removes N6-methyladenosine (meta-effect: decreases IL17A)  \n3) N6-methyladenosine is on IL17A  \n4) IL17A promotes Psoriasis"
}